June 28, 2019
Biophytis Announces Results of 2019 Annual General Meeting of Shareholders. Read the Press Release
Biophytis Announces Results of 2019 Annual General Meeting of Shareholders. Read the Press Release
Biophytis Announces it Presented One Oral and One Poster Presentation at the MaculART meeting in Paris, France. Read the press release
Biophytis Enters into a Collaboration with the French Muscular Dystrophy Association (AFM-Telethon). Read the Press Release
Biophytis Expands Daniel Schneiderman’s Role to Group Chief Financial Officer. Read the Press Release
Biophytis announces suspension of trading until distribution of a press release. Read the Press Release
Biophytis announces the publication of its 2018 Reference Document. Read the press release
Biophytis announces the resumption of the listing of its stock on May 23, 2019, at the opening of the markets. Read the press release
Biophytis Files Registration Statement for Proposed Initial Public Offering in the United States. Read the Press Release
Biophytis Presented A Poster at The Association for Research in Vision and Ophthalmology Annual Meeting. Read the Press Release
Biophytis announces the release of the 2018 Annual Financial Report and the departure of Jean-Gérard Galvez from the Board of Directors. Read the Press Release